South Korea's SK Hynix eyes US listing as soon as August, sources sayThe US Securities and Exchange Commission is likely to approve SK Hynix's American depositary receipt listing application during the week...
Nuvama Wealth receives final SEBI approval to launch mutual fund businessNuvama Wealth Management has received final Sebi approval to enter the mutual fund business through Nuvama Asset Management. The company pl...
US Congress approves $70 billion for Trump immigration crackdownThe US Congress on Tuesday passed a $70 billion bill funding President Donald Trump's hardline immigration crackdown through the rest of hi...
Who is Neeraj Sharma, the Indian-American CEO set to lose US citizenship over H-1B visa fraud for jobs that never existed?An Indian-origin businessman, Neeraj Sharma, is at the center of a US immigration fraud case. Authorities are seeking to revoke his citizen...
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
'Not enough ties to...': Forbes 30 Under 30 Asia entrepreneur denied US visa despite building company with 100+ employeesSwapnil Srivastav, an Asian entrepreneur, was not given a US tourist visa despite building a successful venture-backed startup employing ov...
$10. 6 billion deal: GSK to buy US cancer specialist NuvalentBritish pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...
Trump suddenly finds himself in a perfect storm. Can he survive it?Trump faces mounting challenges this summer, including legal setbacks, weak approval ratings and public anxiety over inflation and fuel pri...
Psychology says people who stopped caring what others think aren’t arrogant or indifferent; they’ve just achieved a level of emotional maturity that comes from finally valuing their own judgment over the opinions of those around themEmotional maturity is frequently misinterpreted as coldness. In reality, psychological insights illustrate that it embodies the journey tow...
Income Tax Department issues ITR scrutiny guidelines: These ITR filers may face compulsory scrutiny in FY 26-27The CBDT has released new guidelines for compulsory income tax return scrutiny in FY 2026-27, impacting returns filed in FY 2025-26. Specif...
US approves $1.5 billion sale of maritime helicopters to New ZealandThe U.S. has approved a $1.5 billion sale of five Seahawk helicopters to New Zealand, a move supporting the nation's plan to nearly double ...
US Senate approves $70 billion for Trump's immigration crackdownThe US Senate on Friday approved $70 billion in funding for Donald Trump's hardline immigration crackdown, handing the president a major vi...
US Development FinCrop to invest $1.5 billion in Indo-Pacific energy platform, eyes South Asia buildoutThe US International Development Finance Corporation is investing $1.5 billion in a new energy platform for the Indo-Pacific. This major pr...
Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...